Premium
Immunization after the elective end of antineoplastic chemotherapy in children
Author(s) -
Fioredda Francesca,
Cavillo Michaela,
Banov Laura,
Plebani Alessandro,
Timitilli Anna,
Castagnola Elio
Publication year - 2009
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.21864
Subject(s) - medicine , blood cancer , immunization , vaccination , cancer , cancer chemotherapy , pediatrics , family medicine , intensive care medicine , immunology , antibody
The aim of the present commentary is to discuss the multifaceted topic of vaccinations after treatment for cancer in the pediatric age. Publications in this field reveal conflicting data and opinions; no evidence‐based guidelines currently exist. However, in spite of several discrepancies some commonly accepted information and conclusions exist. Efforts to find a common strategy of re‐immunization should be directed towards setting up prospective studies on sufficient numbers of patients to obtain statistically relevant end points. Pediatr Blood Cancer 2009;52:165–168. © 2008 Wiley‐Liss, Inc.